On 12 October, 11:00-12:00 CET, the ETUI is hosting a webinar on cancer risks in healthcare workers: identification of Hazardous Medicinal Products (HMPs).
In the healthcare sector, 12.7 million workers across the EU are potentially exposed to Hazardous Medicinal Products (HMPs). While these drugs are vital in the treatment of different diseases (for example, cancers and psoriasis), they can also pose health risks to those exposed to them at work such as nurses, pharmacists and cleaners.
The ETUI has identified 121 HMPs commonly used in the healthcare sector which can cause cancer or reproductive disorders in professionals exposed to them on a daily basis.
As the Carcinogens, Mutagens & Reprotoxic Substances Directive (CMRD – Dir (EU) 2004/37/EC) has been recently revised to specifically cover HMPs, the ETUI list of HMPs is timely to raise awareness about these risks in the healthcare sector and help employers use the European guidelines on the safe management of HMPs to be published soon by the European Commission.
Programme
Welcome and introduction
Claes-Mikael Ståhl, Deputy general secretary, ETUC (tbc)
The ETUI list of Hazardous Medicinal Products (HMPs)
Ian Lindsley, Secretary of the European Biosafety Network
Q&A with the audience moderated by Marian Schaapman, Head of the Working conditions, health and safety unit at the ETUI
Conclusions - Tony Musu, senior researcher in the health and safety and working conditions of the ETUI
Registered address:
Patient Safety Learning, China Works SB203, 100 Black Prince Road Vauxhall, London, SE1 7SJ
Important Information
We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.
